Vaccine Clinical Trial Showcase: Phase 2b HIPRA Study Against COVID-19, Presented by Veristat
Veristat is delighted to present the results of the booster vaccination with PHH-1V (Bimervax®, HIPRA) compared with BNT162b2 mRNA vaccine (Comirnaty®, Pfizer/BioNTech) in adults fully vaccinated with primary series against COVID-19. The combined work of Veristat's Data Management, Clinical Operations, Biostatisticians, Project Management and Medical Monitoring teams was presented at the World Vaccine Congress in Barcelona, 16-19 October, 2023.
downloadExplore Our Key Related Services
Please fill out this form to access your resource.